Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
DomRuinart 
08.02.21 50%
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€36.75
25.01.21
€50.00
25.01.22
-12.24%
08.02.21

Could be worthwhile Investment >10% per year
DomRuinart 
25.01.21 50%
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
23.01.21
€30.00
23.01.22
-67.09%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 50%
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.36
23.01.21
€100.00
23.01.22
-77.10%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 50%
buy
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.62
23.01.21
€60.00
23.01.22
-81.94%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 50%
buy
Teligent Inc.

Start price
Target price
Perf. (%)
€0.99
23.01.21
-
23.01.22
-97.97%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 0%
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35.75
23.01.21
-
23.01.22
-73.67%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 0%
buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€28.25
21.01.21
€120.00
21.01.23
-86.83%
21.01.23

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
21.01.21 50%
buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.50
21.01.21
€10.00
21.01.22
-47.52%
22.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
21.01.21 50%
buy
Lipocine Inc.

Start price
Target price
Perf. (%)
€32.30
21.01.21
€136.00
21.01.22
-57.58%
22.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
21.01.21 50%
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
11.01.21 50%
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
14.12.20 50%
sell
vTv Therapeutics Inc

Start price
Target price
Perf. (%)
€2.30
12.12.20
€1.00
12.12.21
-14.22%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
nvestor 
12.12.20 50%
sell
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€3.78
12.12.20
€2.00
12.12.21
4.76%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
nvestor 
12.12.20 50%
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.12
01.12.20
€20.00
01.12.21
5.26%
14.12.20

Could be worthwhile Investment >10% per year
DomRuinart 
01.12.20 50%
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.00
19.11.20
€50.00
19.11.21
-67.07%
07.11.21

Could be very worthwhile Investment >20% year
marge 
19.11.20 50%
buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€32.66
18.11.20
€60.00
18.11.21
-3.60%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
18.11.20 50%
buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€2.39
18.11.20
€4.00
30.50%
30.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
18.11.20 50%
sell
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.20
16.11.20
-
16.11.21
-77.34%
17.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
WatchMen 
16.11.20 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€12.90
17.10.20
-
04.11.21
-29.07%
24.03.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
FXX 
17.10.20 50%
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€6.10
27.09.20
-
04.11.21
-1.25%
05.11.21

Higher risks for its business
Wann 
27.09.20 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.45
23.09.20
-
04.11.21
-47.51%
15.07.21

Probably not worthwhile Investment
Biotechhunter 
23.09.20 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
22.09.20 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
21.09.20
-
28.09.20
40.54%
28.09.20

Risky Investment
Wolf_of_WS 
21.09.20 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
19.09.20
-
29.09.20
72.97%
29.09.20

High risks for its business
DrMabuse 
19.09.20 50%